🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In the Main Study Phase a total of 246 subjects were randomized 2:2:1 into ...
Status
Completed
Location
Clinical Research Consulting, LLC
Start Date
2019-07-01
Trial ID
NCT03970733
A Phase 2, Randomized, Double-Blind Trial to Evaluate the Safety and Immuno...
Status
Completed
Location
Northwest Arkansas Pediatrics
Start Date
2018-04-16
Trial ID
NCT03512288
Treatments Being Tested
This is a 2-part study to evaluate the immunogenicity, safety, and reactoge...
Status
Completed
Location
Aberdeen Royal Infirmary - PPDS
Start Date
2022-02-16
Trial ID
NCT05249829
Treatments Being Tested
This initial, proof of concept study will focus on identifying significant ...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center Vaccine Research Center
Start Date
2018-11-12
Trial ID
NCT03583606
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill canc...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1999-03
Trial ID
NCT00004052
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Status
Active Not Recruiting
Location
Valley Clinical Trials Inc. ( Site 0002)
Start Date
2020-02-27
Trial ID
NCT04199689
Treatments Being Tested
This is a Phase 1 first-in-human, randomized, controlled, observer-blinded ...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2016-11-03
Trial ID
NCT02955160
Treatments Being Tested
A single arm, open-label, non-randomized, interventional phase 3 study to m...
Status
Unknown
Location
L'Institut National de Recherche Biomédicale RDC
Start Date
2019-11-14
Trial ID
NCT04152486
Treatments Being Tested
This study will evaluate whether V503 (9vHPV vaccine), is well tolerated in...
Status
Completed
Location
Multiple Locations
Start Date
2010-02-24
Trial ID
NCT01047345
Treatments Being Tested
Section 1: The purpose of the study is to obtain safety and immunogenicity...
Status
Completed
Location
Medical University Vienna, Dept. of Clinical Pharmacology
Start Date
2011-03-01
Trial ID
NCT01504347